Endocrinology

DKA Knowledge Challenge!

Diabetic ketoacidosis isn’t just an emergency room concern. It can start with subtle signs you might see first in your patients. This quick quiz zeroes in on the key red flags, risk factors, and management essentials of DKA that every PCP should know. Test your knowledge and sharpen your clinical instincts - it could make all the difference.

Click here to participate in survey

Latest News

GLP-1 Therapy for Obesity Requires Substantial Nutritional Framework, Multidisciplinary Support, Joint Advisory Warns
GLP-1 Therapy for Obesity Requires Substantial Nutritional Framework, Multidisciplinary Support, Joint Advisory Warns

July 9th 2025

GLP-1 medications are transforming obesity medicine but strong evidence points to a need for integrating nutrition and lifestyle support for lasting weight loss and health benefits.

BF% outperforms BMI in Predicting Morality risk in young adults: New Findings / image courtesy of University of Florida
Body Fat Percentage Outperforms BMI in Predicting Mortality Risk in Young Adults: New Findings

July 8th 2025

Novel GLP-1/GLP-2 Agent Reduces Body Weight by Up to 8.3% in Phase 1b Obesity Trial
Novel GLP-1/GLP-2 Agent Reduces Body Weight by Up to 8.3% in Phase 1b Obesity Trial

July 7th 2025

Once-Monthly Maridebart Cafraglutide Produces Up to 20% Weight Loss in Phase 2 Trial
Once-Monthly Maridebart Cafraglutide Produces Up to 20% Weight Loss in Phase 2 Trial

June 26th 2025

Viking Advances GLP-1/GIP Agonist VK2735 into Late Stage Clinical Program for Obesity   / image credit ©Viking Therapeutics
Viking Advances GLP-1/GIP Agonist VK2735 into Late Stage Clinical Program for Obesity

June 26th 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.